Shaobin Wu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in ⓘ
-
- Wnt/β-catenin signaling in development and cancer 3
- Genomics and Phylogenetic Studies 3
- RNA Research and Splicing 2
-
- MicroRNA in disease regulation 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Zhikang Chen (9 shared papers)Jie Ge (8 shared papers)Zihua Chen (8 shared papers)Weijie Yuan (7 shared papers)Xianwei Wang (4 shared papers)Jin-Xiang Chen (3 shared papers)Jinxiang Chen (3 shared papers)Yuxiang Chen (1 shared paper)
- Journals
- OncoTargets and Therapy (2 papers)Zootaxa (1 paper)Medical Oncology (1 paper)Pathology & Oncology Research (1 paper)Laboratory Investigation (1 paper)
- Partner nations
- ChinaIrelandUnited States
In The Last Decade
Shaobin Wu
21 papers receiving 703 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 305
- Molecular Biology 489
- Cellular and Molecular Neuroscience 108
- Oncology 135
- Cell Biology 69
Countries citing papers authored by Shaobin Wu
This map shows the geographic impact of Shaobin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobin Wu more than expected).
Fields of papers citing papers by Shaobin Wu
This network shows the impact of papers produced by Shaobin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobin Wu. The network helps show where Shaobin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaobin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 98 | |
| 2 | 2020 | 78 | |
| 3 | 2013 | 67 | |
| 4 | 2008 | 59 | |
| 5 | 2019 | 54 | |
| 6 | 2019 | 50 | |
| 7 | 2011 | 42 | |
| 8 | 2008 | 42 | |
| 9 | 2020 | 40 | |
| 10 | 2009 | 40 | |
| 11 | 2010 | 35 | |
| 12 | 2008 | 32 | |
| 13 | 2015 | 23 | |
| 14 | 2014 | 12 | |
| 15 | 2019 | 8 | |
| 16 | 2008 | 8 | |
| 17 | Genetic diversity analysis of Macaca thibetana based on mitochondrial DNA control region sequences. | 2008 | 8 |
| 18 | 2021 | 7 | |
| 19 | 2008 | 5 | |
| 20 | 2017 | 2 |
About Shaobin Wu
Shaobin Wu is a scholar working on Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience, Oncology and Surgery, having authored 22 papers that have together received 712 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (3 papers), Genomics and Phylogenetic Studies (3 papers), Axon Guidance and Neuronal Signaling (3 papers), MicroRNA in disease regulation (2 papers), Primate Behavior and Ecology (2 papers), RNA Research and Splicing (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (305 citations), Molecular Biology (489 citations), Cellular and Molecular Neuroscience (108 citations), Oncology (135 citations) and Cell Biology (69 citations). Shaobin Wu has collaborated with scholars based in China, Ireland and United States. Frequent co-authors include Zhikang Chen, Jie Ge, Zihua Chen, Weijie Yuan, Xianwei Wang, Jin-Xiang Chen, Jinxiang Chen, Yuxiang Chen, Futao Hou and Bin Hu. Their work appears in journals such as OncoTargets and Therapy, Zootaxa, Medical Oncology, Pathology & Oncology Research and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.